Virus Transmission
Virus Transmission
批准号:
10221480
负责人:
Pamela J Bjorkman
金额:
$50.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-27 至 2022-07-31
关键词:
3-DimensionalAIDS/HIV problemAnimal ModelAnimalsAntiviral TherapyArchitectureAreaBiological AssayBioluminescenceCD4 Positive T LymphocytesCell fusionCell membraneCellsCellular MembraneCellular biologyCessation of lifeChildCryoelectron MicroscopyDataDockingElectronsElementsEventFamilyFluorescenceFutureHIVHIV InfectionsHIV-1HealthHumanImageImaging TechniquesImmuneIn VitroIndividualIntegral Membrane ProteinKineticsKnowledgeLaser Scanning MicroscopyLettersLightLipidsMediatingMicro Electron DiffractionMicroscopyMolecular ConformationMonitorMothersMothsOpticsPathogenesisPathogenicityPlastic EmbeddingPositron-Emission TomographyPreventive vaccineProcessProteinsResolutionSIVSerineSurfaceSystemT-Cell DepletionTestingTherapeuticTimeTissue SampleTissuesTropismVaccinesVariantVesicleViralViral PathogenesisViral ProteinsVirionVirusVisualizationX-Ray Crystallographyantibody-dependent cell cytotoxicityantiretroviral therapycomparativeelectron crystallographyelectron tomographyexperimental studyhumanized mouseimaging approachimprovedin vivoinhibitor/antagonistmembermouse modelnef Proteinpandemic diseaseparticlereceptorsingle-molecule FRETstructural biologysuccesstraffickingtransmission processtwo-photonviral transmissionvirologywhole animal imaging
中文摘要
摘要
艾滋病毒/艾滋病大流行仍然是人类健康的全球负担1,尽管抗逆转录病毒疗法(抗逆转录病毒疗法)
减少艾滋病毒感染的死亡,预防性疫苗(S)和数百万感染者的功能性治疗是
在这些领域取得成功需要更好地了解艾滋病毒的传播和传播
以及CD4T细胞耗尽的机制,这是免疫缺陷的标志。
正在开发针对HIV包膜(Env)的抗病毒疗法和疫苗,Env是病毒表面唯一的病毒蛋白
HIV病毒4,5需要了解它的构象动力学以及它是如何被病毒宿主细胞激活的
核聚变。我们建议通过成像实验填补这些知识空白,这些实验将:1)可视化
HIV-1在人源化小鼠模型和非人灵长类动物中传播6-9,2)
确定CD4耗尽的原因并可视化病毒限制背后的细胞事件,3)描述
HIV Env三聚体如何被激活以进行融合10、11和4)确定Env如何被宿主细胞限制所抑制
12-14这种方法将揭示病毒传播的瓶颈,机制
限制,以及在激活艾滋病毒环境中可用于治疗的漏洞。
英文摘要
ABSTRACT
The HIV/AIDS pandemic remains a global burden on human health.1 Although antiretroviral therapy (ART)
reduces deaths from HIV infection, prophylactic vaccine(s) and a functional cure for the millions infected are
lacking.2 Success in these areas will require improved understanding of HIV transmission and dissemination
and the mechanism of CD4 T cell depletion, which is the hallmark of immune deficiency.3 In addition,
developing antiviral therapies and vaccines against HIV envelope (Env), the only viral protein on the surface of
the HIV virion4,5, requires understanding its conformational dynamics and how it is activated for virus–host cell
fusion. We propose to fill these knowledge gaps through imaging experiments that will: 1) Visualize the
dissemination of HIV-1 following transmission in humanized mouse models and non-human primates6-9, 2)
Determine the cause of CD4 depletion and visualize cellular events underlying viral restriction, 3) Delineate
how the HIV Env trimer is activated for fusion10,11, and 4) Define how Env is inhibited by host cell restriction
proteins of the SERINC family.12-14 This approach will reveal bottlenecks in virus dissemination, mechanisms of
restriction, and vulnerabilities in activating HIV Env that can be exploited therapeutically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination
-
批准号:10327994
-
项目类别:
-
资助金额:$150.76万
-
财政年份:2022
-
负责人:Pamela J Bjorkman
-
依托单位:
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
-
批准号:10508317
-
项目类别:
-
资助金额:$116.03万
-
财政年份:2022
-
负责人:Pamela J Bjorkman
-
依托单位:
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
-
批准号:10663363
-
项目类别:
-
资助金额:$170.74万
-
财政年份:2022
-
负责人:Pamela J Bjorkman
-
依托单位:
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination
-
批准号:10841242
-
项目类别:
-
资助金额:$97.15万
-
财政年份:2022
-
负责人:Pamela J Bjorkman
-
依托单位:
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates
-
批准号:10398152
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2021
-
负责人:Pamela J Bjorkman
-
依托单位:
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates
-
批准号:10614987
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2021
-
负责人:Pamela J Bjorkman
-
依托单位:
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates
-
批准号:10205734
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2021
-
负责人:Pamela J Bjorkman
-
依托单位:
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1
-
批准号:10458249
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2021
-
负责人:Pamela J Bjorkman
-
依托单位:
Enhancement of the HIV Antibody Database tool for Open Science
-
批准号:10406832
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2021
-
负责人:Pamela J Bjorkman
-
依托单位:
Project 2
-
批准号:9982207
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2018
-
负责人:Pamela J Bjorkman
-
依托单位:
Project 2
-
批准号:10454950
-
项目类别:
-
资助金额:$50.97万
-
财政年份:2018
-
负责人:Pamela J Bjorkman
-
依托单位:
Project 2
-
批准号:10216968
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2018
-
负责人:Pamela J Bjorkman
-
依托单位:
Targeting the HIV reservoir using optimized anti-HIV antibodies
-
批准号:9273865
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2017
-
负责人:Pamela J Bjorkman
-
依托单位:
Targeting the HIV reservoir using optimized anti-HIV antibodies
-
批准号:10179304
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2017
-
负责人:Pamela J Bjorkman
-
依托单位:
Core A: Automated Cell/Biochemical Assays Core
-
批准号:10307760
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位:
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
-
批准号:8617121
-
项目类别:
-
资助金额:$263.67万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位:
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
-
批准号:8786046
-
项目类别:
-
资助金额:$210.03万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位:
Core A: Automated Cell/Biochemical Assays Core
-
批准号:10710276
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位:
Core C: Administrative Core
-
批准号:10710275
-
项目类别:
-
资助金额:$13.84万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位:
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs
-
批准号:10307762
-
项目类别:
-
资助金额:$63.6万
-
财政年份:2013
-
负责人:Pamela J Bjorkman
-
依托单位: